A detailed history of Mission Creek Capital Partners, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Mission Creek Capital Partners, Inc. holds 11,442 shares of NVO stock, worth $1.63 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
11,442
Previous 7,822 46.28%
Holding current value
$1.63 Million
Previous $809,000 81.58%
% of portfolio
0.38%
Previous 0.21%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$102.11 - $135.92 $369,638 - $492,030
3,620 Added 46.28%
11,442 $1.47 Million
Q4 2023

Feb 14, 2024

SELL
$87.78 - $105.45 $8,778 - $10,545
-100 Reduced 1.26%
7,822 $809,000
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $330,203 - $724,529
3,631 Added 84.62%
7,922 $720,000
Q2 2023

Aug 14, 2023

SELL
$155.98 - $172.65 $154,264 - $170,750
-989 Reduced 18.73%
4,291 $694,000
Q1 2023

May 12, 2023

SELL
$132.34 - $159.14 $7,278 - $8,752
-55 Reduced 1.03%
5,280 $840,000
Q4 2022

Feb 13, 2023

SELL
$102.55 - $135.33 $48,711 - $64,281
-475 Reduced 8.18%
5,335 $721,000
Q3 2022

Nov 14, 2022

SELL
$95.28 - $116.93 $9,528 - $11,693
-100 Reduced 1.69%
5,810 $579,000
Q4 2021

Feb 14, 2022

SELL
$95.88 - $117.08 $19,176 - $23,416
-200 Reduced 3.27%
5,910 $662,000
Q3 2021

Nov 15, 2021

SELL
$84.42 - $106.62 $20,260 - $25,588
-240 Reduced 3.78%
6,110 $587,000
Q2 2021

Aug 13, 2021

SELL
$67.66 - $84.76 $6,766 - $8,476
-100 Reduced 1.55%
6,350 $532,000
Q3 2020

Nov 13, 2020

SELL
$63.69 - $70.22 $4,585 - $5,055
-72 Reduced 1.1%
6,450 $448,000
Q2 2020

Aug 14, 2020

SELL
$58.54 - $67.94 $27,806 - $32,271
-475 Reduced 6.79%
6,522 $427,000
Q1 2020

May 14, 2020

SELL
$49.46 - $64.78 $4,946 - $6,478
-100 Reduced 1.41%
6,997 $421,000
Q4 2019

Feb 14, 2020

BUY
$49.86 - $58.26 $353,856 - $413,471
7,097 New
7,097 $411,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $322B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Mission Creek Capital Partners, Inc. Portfolio

Follow Mission Creek Capital Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mission Creek Capital Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mission Creek Capital Partners, Inc. with notifications on news.